The presence of anti-HBs early in infection may block the detection of low levels of HBsAg by current assays since HBsAg assays rely on monoclonal antibodies directed at the S protein, particularly the immunodominant ‘a’ determinant, the same protein that is used in recombinant hepatitis B vaccines. Here, PROS1 is linked to hepatitis B virus infection.